Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al., (ed.), Birhauser, Boston, MA, pp. 433 and 492-495). |
French et a., Analytical Biochemistry, vol. 228, 2:354-355, 1995. |
Crystal, Science, vol. 270, pp. 404-409, 1995. |
Chakraborty et al., Cancer Gene Therapy, vol. 1, 2: 113-118, 1994. |
Coghlan, New Scientist, vol. 148, pp. 14-15, 1995. |
Mastrangelo et al., vol. 23, 1, pp. 4-21, 1996. |
Miller et al., The FASEB J, vol. 9, 190-199, 1995. |
Marshall, E., "Gene Therapy's Growing Pains", Science, vol. 269, 1050-1055, (Aug. 25, 1995). |
Mullins, J.J., et al., "Transgenesis in Nonmurine Species", Hypertension, 22, No. 4, 630-633, (1993). |
Wall, R.J., "Transgenic Livestock: Progress and Prospects for the Future", Theriogenology, 45, 57-68, (1996). |
Rogers, J.A., et al., "A Tumor Necrosis Factor-Responsive Long-Term-Culture-Initiating Cell is Associated with the Stromal Layer of Mouse Long-Term Bone Marrow Cultures", Proc. Natl. Acad. Sci. USA, 90, 5777-5780, (Jun., 1993). |
"Patent Search: Genetic Vectors, Transduction, Genetic Transfection", Oct. 1990 (a copy of a computer generated search was submitted with the PTO 1449 of the parent application. |
Adams, S.E., et al., "Complete Nucleotide Sequence of a Mouse VL30 Retro-Element", Molecular and Cellular Biology, 8, 2989-2998, (Aug., 1988). |
Anderson, W.F., "Human Gene Therapy", Science, 256, 808-813, (May, 1992). |
Anderson, W.F., "Prospects for Human Gene Therapy", Science, 226, 401-409, (Oct., 1984). |
Bestwick, R.K., et al., "Overcoming Interference to Retroviral Superinfection Results in Amplified Expression and Transmission of Cloned Genes", Proc. Natl. Acad. Sci. USA, 85, 5404-5408, (Aug., 1988). |
Boeke, J.D., et al., "A General Method for the Chromosomal Amplification of Genes in Yeast", Science, 239, 280-282, (Jan., 1988). |
Carter, A.T., et al., "A Novel Approach to Cloning Transcriptionally Active Retrovirus-Like Genetic Elements from Mouse Cells", Nucleic Acids Research,11, 6243-6254, (1983). |
Chakraborty, A.K., et al., "Synthetic Retrotransposon VL30 Vectors For Gene Therapy, Transgenics and Research", Miami Short Reports, 99-100, (1994). |
Chakraborty, A.K., et al., "Transmission of Endogenous VL30 Retrotransposons by Helper Cells Used in Gene Therapy", Cancer Gene Therapy, 1, 113-118, (1994). |
Chakroborty, A.K., et al., "Synthetic Retrotransposon Vectors for Gene Therapy", FASEB Journal, Methodology Communications, 7, 971-977, (Jul., 1993). |
Chakroborty, A.K., et al., "Synthetic Retrotransposon VL30 Derived Vectors for Gene Therapy", J. Cell. Biol., Suppl. 17E, Abstract No. SZ 302, 235, (1993). |
Cook, R.F., et al., "Liver-Specific Expression of a Phosphoenolpyruvate Carboxykinase-neo Gene in Genetically Modified Chickens", Poultry Science, 72, 554-567, (1993). |
Cook, R.F., et al., "Retrotransposon Gene Engineering", Bio/Technology, 9, 748-751, (Aug., 1991). |
Cosgrove, D.E., et al., "Transgenic Animal Models and Gene Therapy", Exp. Opin. Ther. Patents, 4, 237-245, (1994). |
Cosgrove, et al., "VL30 Vectoring Systems: Some Surprises in Their Regulation in Embryonic Stem Cells", J. Cell. Biochem., Suppl. 17E, Abstract No. SZ 303, 235, (1993). |
Culver, K.W., et al., "Gene Therapy for Cancer", TIG, 10, 174-178, (May, 1994). |
Donahue, R.E., et al., "Helper Virus Induced T Cell Lymphoma in Nonhuman Primates After Retroviral Mediated Gene Transfer", J. Exp. Med., 176, 1125-1135, (Oct., 1992). |
First, N.L., "New Animal Breeding Techniques and Their Application", J. Reprod. Fertil., Suppl. 41, 3-14, (1990). |
Foster, D.N., et al., "Isolation of Mouse DNA Segments Containing Epidermal Growth Factor (EGF) Inducible Sequences", J. Cell Biochem., (Suppl), 6, 285, (1982). |
Foster, D.N., et al., "Polyadenylylated RNA Complementary to a Mouse Retrovirus-Like Multigene Family is Rapidly and Specifically Induced by Epidermal Growth Factor Stimulation of Quiescent Cells", Proc. Nat'l Acad. Sci. USA, 79, 7317-7321, (Dec., 1982). |
Giri, C.P., et al., "Discrete Regions of Sequence Homology Between Cloned Rodent VL30 Genetic Elements and AKV-Related MuLV Provirus Genomes", Nucleic Acids Research, 11, 305-319, (1983). |
Hatzoglou, M., et al., "Dexamethasone Regulated Expression of Mouse VL30 Retrotransposons in Rat Cells Upon Infection with Recombinant MoMLV Viruses", J. Cell. Biochem., Abstract D411, 368, (1990). |
Hatzoglou, M., et al., "Efficient Packaging of a Specific VL30 Retroelement by .psi.2 Cells Which Produce MoMLV Recombinant Retroviruses", Human Gene Therapy, 1, 385-397, (1990). |
Hatzoglou, M., et al., "Hepatic Gene Transfer in Animals Using Retroviruses Containing the Promoter from the Gene for Phosphoenolpyruvate Carboxykinase", Journal of Biological Chemistry, 265, 17285-17293, (Oct., 1990). |
Hennighausen, L., "The Mammary Gland as a Bioreactor: Production of Foreign Proteins in Milk", In: Protein Expression and Purification, vol. 1, 3-8, (1990). |
Hodgson, C.P., et al., "Gene Engineering with Retrotransposon Vectors", Advances in Gene Technology: The Molecular Biology of Human Genetic Disease, Miami Symposia, 44, (1991). |
Hodgson, C.P., et al., "Mouse Retrovirus-Like (VL30) Transposable Element RNA is Abundantly Expressed in PSI-2 Helper Cells, Transferred to Recipient Rat Hepatoma Cells, and Expressed in a Dexamethasone-Inducible Fashion Along with Specifically Vectored Sequences: Complete Structure", J. Cellu. Biochem., 13D, 54, (1989). |
Hodgson, C.P., et al., "Nucleotide Sequence of Mouse Virus-like (VL30) Retrotransposon BVL-1", Nucleic Acids Research, 18, 673, (1990). |
Hodgson, C.P., et al., "Retroviral Vectors for Gene Therapy and Transgenics", Curr. Opin. Invest. Drugs, 2, 205-216, (Mar., 1993). |
Hodgson, C.P., et al., "Retroviral Vectors for Gene Therapy and Transgenics", Curr. Opin. Therap. Patents, 3, 223-235, (Feb., 1993). |
Hodgson, C.P., et al., "Structure and Expression of Mouse VL30 Genes", Molec. Cell. Biol., 3, 2221-2231, (Dec., 1983). |
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene", Dissertation Abstracts International, 44, 700B, (1983). |
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of a Mouse Virus-Like Genetic Element", DNA, 2, 83, (1983). |
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene", Doctoral Dissertation, University of Minnesota, (Feb., 1983). |
Hoeben, R.C., et al., "Inactivation of the Moloney Murine Leukemia Virus Long Terminal Repeat in Murine Fibroblast Cell Lines Is Associated with Methylation and Dependent on Its Chromosomal Position", J. Virol., 65, 904-912, (Feb., 1991). |
Jaenisch, R., et al., "Chromosomal Position and Activation of Retroviral Genomes Inserted into the Germ Line of Mice", Cell, 24, 519-529, (May, 1981). |
Jaenisch, R., "Germ Line Integration and Mendelian Transmission of the Exogenous Moloney Leukemia Virus", Proc. Nat. Acad. Sci. USA, 7376), 1260-1264, (Apr., 1976). |
Jaenisch, R., "Transgenic Animals", Science, 240, 1468-1474, (Jun., 1988). |
Kantoff, P.W., et al., "Expression of Human Adenosine Deaminase in Nonhuman Primates After Retrovirus-Mediated Gene Transfer.", J. Exp. Med, 16, 219-234, (Jul., 1987). |
Markowitz, D., et al., "A Safe Packaging Line for Gene Transfer: Separating Viral Genes on Two Different Plasmids", J. Virol., 62, 1120-1124, (Apr., 1988). |
Markowitz, D., et al., "Construction and Use of a Safe and Efficient Amphotropic Packaging Cell Line", Virol., 167, 400-406, (1988). |
McClintock, B., "Controlling Elements and the Gene", Cold Spring Harbor Symp. Quant. Biol., 6, 197-216, (1957). |
Menendez-Arias, et al., "Purification and Characterization of the Mouse Mammary Tumor Virus Protease Expressed in Escherichia coli", J. Biol. Chem., 267, 24134-24139, (1992). |
Miller, A.D., "Human Gene Therapy Comes of Age", Nature, 357, 455-460., (Jun. 11, 1992). |
Miller, A.D., et al., "Redesign of Retrovirus Packaging Cell Lines to Avoid Recombination Leading to Helper Virus Production", Molec. Cell. Biol., 6, 2895-2902, (Aug., 1986). |
Norton, J.D., et al., "Temporal and Tissue-Specific Expression of Distinct Retrovirus-Like (VL30) Elements During Mouse Development", Develop. Biol., 125, 226-228, (1988). |
Rosenberg, S.A., "Gene Therapy for Cancer", JAMA, 268, 2416-2419, (Nov., 1992). |
Rosenberg, S.A., et al., "Gene Transfer Into Humans--Immunotherapy of Patients with Advanced Melanoma, Using Tumor Infiltrating Lymphocytes Modified by Retroviral Gene Transduction", The New England Journal of Medicine, 323, 570-578, (Aug., 1990). |
Rotman, C., et al., "Promoter and Enhancer Activities of Long Terminal Repeats Associated with Cellular Retrovirus-like (VL30) Elements", Nuc. Acids Res., 14, 645-658, (1986). |
Salter, D.W., et al., "Artificial Insertion of a Dominant Gene for Resistance to Avian Leukosis virus into the Germ Line of the Chicken", Theoretical and Applied Genetics, 77, 457-461, (1989). |
Scadden, D.T., et al., "Human Cells Infected with Retrovirus Vectors Acquire an Endogenous Murine Provirus", Journal of Virology, 64, 424-427, (Jan., 1990). |
Singleton, P., et al., Dictionary of Microbiology and Molecular Biology, 753-756, (1987 ed.). |
Temin, H.M., "Retrovirus Variation and Evolution", Genome, 31, 17-22, (1989). |
Vile, R., et al., "Gene Transfer Technologies for the Gene Therapy of Cancer", Gene Therapy, 1, 88-98, (1994). |
Wagner, E.F., et al., "The Human .beta.-Globin Gene and A Functional Viral Thymidine Kinase Gene in Developing Mice", Proc. Natl. Acad. Sci. USA, 78, 5016-5020, (Aug., 1981). |